Uncommon Bio
4 known investors
Find your way into Uncommon Bio
Uncommon Bio has sold its cultivated meat platform to Vow and is now focusing on SymphoRNA, leveraging its nucleic acid delivery technology.
Investors · 4
In the news
Frequently asked questions
- What does Uncommon Bio do?
- Uncommon Bio has sold its cultivated meat platform to Vow and is now focusing on SymphoRNA, leveraging its nucleic acid delivery technology.
- Who are Uncommon Bio's investors?
- Uncommon Bio's investors include Angel Academe, Balderton Capital, Global Brain, redalpine.